The size of the Needles Market in Europe was valued at USD 1.62 billion in 2021. It is estimated to be growing at a CAGR of 7.85%, to reach USD 2.36 billion by 2026.
The market is showcasing high growth potential in the mentioned period. It will continue to expand with the recent developments in the Pharmaceutical industry.
The European needles market is primarily driven by the factors such as the proliferation of chronic diseases across Europe and increasing inclination for biosimilars drugs. However, favorable reimbursement scenarios in the European countries encourage the entrance of new market players for the Needles. Also, the rising geriatric population increases the market growth to some extent. In addition, a growing number of hospitals in the developed countries such as the United Kingdom, Germany, and Spain are majorly witnessing market growth. Moreover, rising demand for the vaccine across Europe influences the demand for the needles through which market growth can be increased. Over the years, increasing awareness among the people for blood donation in the region is expected to uplift the market growth. The rising incidence of accidents, including road accidents, trauma events, and burns across Europe, is more likely to increase the market growth. The UK has been reported a rise in the incidence of burns wounds in the recent past.
Furthermore, the prevalence of diabetes, both type 1 and type 2, is expected to propel needle market growth in the region. A growing number of surgeries is due to the high incidence rate of surgical site infection is also projected to grow. Moreover, Filter needles are used to drain pus and blood from infected wounds and inject medicine to promote wound healing. Filter needles market growth is estimated to be boosted by such factors over the projected period. However, increasing investments by the government and private organizations are encouraging market growth.
There are several incidents of needle stick injuries and infections that negatively impact the European needles market growth. However, the lack of skilled professionals in the region is expected to restrain the market growth.
This research report on the Europe Needles Market has been segmented and sub-segmented into the following categories and analyzed market size and forecast for each segment until 2026.
By Type:
By Product:
By Delivery Mode:
By Material:
By End User:
By Country:
Regional Analysis:
The European needles market is expected to account for a significant share globally during the forecast period. The market growth in the region is attributed to the rising prevalence of diabetes, supportive reimbursement scenarios for needles, and raising awareness across the region. Other factors such as developing healthcare infrastructure and growing population are driving the market growth. Lancets and pen needles are essential for various testing and medication delivery procedures. Lancets were first launched in 1992 to collect blood samples for various tests such as allergy tests, screening tests, cholesterol tests, etc. Diabetes is a lifestyle disease that develops due to a lack of exercise, obesity, and unhealthy foods. According to the World Health Organization, diabetes affects 9% of Europe's population, or 62 million people, whereas it affects 25 million people in Africa. The market for pen needles and lancets in Europe, the Middle East, and Africa is predicted to increase at a CARG of 7.5 percent between 2017 and 2021. The market is also growing due to an increase in the number of biological tests available.
In the regional market, UK, Germany, France, Spain, and Italy are majorly contributing to the European market growth. The United Kingdom is the fastest growing country in Europe over the forecast period. The market is driven by increasing diabetes in the country, and in the recent period, the UK has been reported a rise in the incidence of burns wounds.
KEY MARKET PLAYERS:
Notable companies leading the Europe Needles Market profiled in the report are Becton, Dickinson and Company, B. Braun Melsungen AG, Terumo Corporation and Smiths Medical, Terumo Corporation, Smiths Medical, and Thermo Fisher Scientific.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Type
5.1.1 Introduction
5.1.2 Conventional Needles
5.1.3 Bevel Needles
5.1.4 Filter Needles
5.1.5 Vented Needles
5.1.6 Safety Needles
5.1.7 Active needles
5.1.8 Passive Needles
5.1.9 Y-o-Y Growth Analysis, By Type
5.1.10 Market Attractiveness Analysis, By Type
5.1.11 Market Share Analysis, By Type
5.2 Product
5.2.1 Introduction
5.2.2 Suture Needles
5.2.3 Blood Collection Needles
5.2.4 Ophthalmic Needles
5.2.5 Dental Needles
5.2.6 Insufflation Needles
5.2.7 Pen Needles
5.2.8 Other Needles
5.2.9 Y-o-Y Growth Analysis, By Product
5.2.10 Market Attractiveness Analysis, By Product
5.2.11 Market Share Analysis, By Product
5.3 Delivery Mode
5.3.1 Introduction
5.3.2 Hypodermic Needles
5.3.3 Intravenous Needles
5.3.4 Intramuscular Needles
5.3.5 Intraperitoneal Needles
5.3.6 Y-o-Y Growth Analysis, By Delivery Mode
5.3.7 Market Attractiveness Analysis, By Delivery Mode
5.3.8 Market Share Analysis, By Delivery Mode
5.4 Material
5.4.1 Introduction
5.4.2 Stainless Steel Needles
5.4.3 Plastic Needles
5.4.4 Glass Needles
5.4.5 PEEK Needles
5.4.6 Y-o-Y Growth Analysis, By Material
5.4.7 Market Attractiveness Analysis, By Material
5.4.8 Market Share Analysis, By Material
5.5 End User
5.5.1 Hospitals & Clinics
5.5.2 Diagnostic Centers
5.5.3 Home Healthcare
5.5.4 Other End Users
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Type
6.1.3.3 By Product
6.1.3.4 By Delivery Mode
6.1.3.5 By Material
6.1.3.6 By End User
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Type
6.1.4.3 By Product
6.1.4.4 By Delivery Mode
6.1.4.5 By Material
6.1.4.6 By End User
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Type
6.1.5.3 By Product
6.1.5.4 By Delivery Mode
6.1.5.5 By Material
6.1.5.6 By End User
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Becton
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Dickinson and Company
8.3 B. Braun Melsungen AG
8.4 Terumo Corporation and Smiths Medical
8.5 Thermo Fisher Scientific
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Feb 2020
